首页> 美国卫生研究院文献>Journal of Enzyme Inhibition and Medicinal Chemistry >Synthesis biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors
【2h】

Synthesis biological activity and multiscale molecular modeling studies for coumaryl-carboxamide derivatives as selective carbonic anhydrase IX inhibitors

机译:香豆基甲酰胺衍生物作为选择性碳酸酐酶IX抑制剂的合成生物活性和多尺度分子建模研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

New coumaryl-carboxamide derivatives with the thiourea moiety as a linker between the alkyl chains and/or the heterocycle nucleus were synthesized and their inhibitory activity against the human carbonic anhydrase (hCA) isoforms hCA I, II, VII and IX were evaluated. While the hCA I, II and VII isoforms were not inhibited by the investigated compounds, the tumour-associated isoform hCA IX was inhibited in the high nanomolar range. 2-Oxo-N-((2-(pyrrolidin-1-yl)ethyl)carbamothioyl)-2H-chromene-3-carboxamide (>e11) exhibited a selective inhibitory action against hCA IX with the Ki of 107.9 nM. In order to better understand the inhibitory profiles of studied molecules, multiscale molecular modeling approaches were used. Different molecular docking algorithms were used to investigate binding poses and predicted binding energies of studied compounds at the active sites of the CA I, II, VII and IX isoforms.
机译:合成了具有硫脲部分作为烷基链和/或杂环核之间的连接基的新香豆素-羧酰胺衍生物,并评估了它们对人碳酸酐酶(hCA)亚型hCA I,II,VII和IX的抑制活性。尽管hCA I,II和VII同工型不受所研究化合物的抑制,但与肿瘤相关的同工型hCA IX在高纳摩尔范围内受到抑制。 2-Oxo-N-(((2-(吡咯烷基-1-基)乙基)氨基甲硫酰基)-2H-色烯-3-羧酰胺(> e11 )对Ki的hCA IX表现出选择性抑制作用107.9 nM。为了更好地了解所研究分子的抑制特性,使用了多尺度分子建模方法。使用了不同的分子对接算法来研究化合物在CA I,II,VII和IX同工型的活性位点的结合姿势和预测的结合能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号